Digestive & Intestinal Remedies (Pharmacies) - Malta

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$9.76m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.40%, resulting in a market volume of US$10.45m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$18.17 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Malta is experiencing steady growth and development. Customer preferences in the market are driven by a desire for effective and convenient remedies for digestive and intestinal issues. Additionally, local special circumstances and underlying macroeconomic factors contribute to the market's trends. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Malta are influenced by a number of factors. Consumers in Malta are increasingly seeking out remedies that provide quick relief from digestive and intestinal issues such as indigestion, heartburn, and bloating. They are also looking for products that are easy to use and do not require a prescription. This preference for convenience and accessibility has led to an increase in the demand for over-the-counter remedies in pharmacies. Trends in the market show a shift towards natural and herbal remedies. Consumers in Malta are becoming more health-conscious and are seeking out products that are made from natural ingredients. This trend is driven by a desire for safer and gentler remedies that have fewer side effects. As a result, pharmacies in Malta are stocking a wider range of natural and herbal remedies for digestive and intestinal issues. Local special circumstances in Malta also contribute to the development of the Digestive & Intestinal Remedies (Pharmacies) market. The Maltese diet, which is rich in Mediterranean cuisine, can sometimes lead to digestive issues. This has created a demand for remedies that specifically target these issues. Pharmacies in Malta are responding to this demand by offering a variety of products that address common digestive problems associated with the local diet. Underlying macroeconomic factors also play a role in the growth of the Digestive & Intestinal Remedies (Pharmacies) market in Malta. The country's strong economy and high standard of living have resulted in increased disposable income for consumers. This has allowed them to spend more on healthcare products, including remedies for digestive and intestinal issues. The growing tourism industry in Malta has also contributed to the market's growth, as visitors often seek out remedies for common travel-related digestive problems. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Malta is developing due to customer preferences for effective and convenient remedies, a trend towards natural and herbal products, local special circumstances related to the Maltese diet, and underlying macroeconomic factors such as disposable income and tourism. As the market continues to grow, pharmacies in Malta are likely to expand their offerings to meet the evolving needs of consumers.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.